What is Utah Medical Products's AOCI?

Utah Medical Products (UTMD) reported AOCI of -$9.92M in Q1 2026.

How has Utah Medical Products's AOCI changed year-over-year?

Utah Medical Products's AOCI increased by 11.4% year-over-year, from -$11.19M to -$9.92M.

What is the long-term trend for Utah Medical Products's AOCI?

Over 5 years (2020 to 2025), Utah Medical Products's AOCI has grown at a 2.6% compound annual growth rate (CAGR), from -$8.28M to -$9.42M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Utah Medical Products UTMD AOCI

AOCI at other companies

Becton, Dickinson and CompanyBDX

-$1.76B-2.8%

TFX

TeleflexTFX

-$239.47M+24.4%

The Cooper Companies, Inc.COO

-$363.2M+7.4%

IAR

Integra LifeSciencesIART

-$30.94M-28.3%

Merit Medical SystemsMMSI

-$7.57M+50.8%

Pediatrix Medical GroupMD

$77K+126%

Other financials

Income statement

See full

Revenue$8.7M-10.2%

Gross profit$5.3M-4.6%

Operating income$2.6M-18.6%

Net income$2.6M-14.4%

EPS (diluted)$0.82-10.9%

Balance sheet

See full

Cash & equivalents$87.4M+4.9%

Total debt$210.0K—

Total equity$120.4M+2.8%

Total assets$124.4M+1.5%

Cash flow

See full

Operating cash flow$3.1M-30.4%

CapEx$130.0K-29.3%

Free cash flow$3.0M-30.4%

Valuation

See full

Market cap$219.63M+26.4%

Enterprise value$132.44M+42.5%

P/E20.3×+6.4×

P/S5.9×+1.4×

Profitability

See full

Gross margin57.9%-0.4pp

Operating margin28.8%-3.9pp

Net margin28.9%-4.1pp

FCF margin34.7%0.0pp

Returns & leverage

See full

Return on equity9.1%-1.4pp

Debt / equity0×—

Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossBeforeTax1.

The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Utah Medical Products's AOCI?: Utah Medical Products (UTMD) reported AOCI of -$9.92M in Q1 2026.
How has Utah Medical Products's AOCI changed year-over-year?: Utah Medical Products's AOCI increased by 11.4% year-over-year, from -$11.19M to -$9.92M.
What is the long-term trend for Utah Medical Products's AOCI?: Over 5 years (2020 to 2025), Utah Medical Products's AOCI has grown at a 2.6% compound annual growth rate (CAGR), from -$8.28M to -$9.42M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.